Versant Venture Capital VI, L.P. (CIK 0001687880)

Latest company ownership

Shares held
3,297,115
Last filed at
Aug 12, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q3 2025Q4
Shares held
2,846,941
Last filed at
Jul 10, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4
Shares held
2,480,623
Last filed at
Aug 30, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
Shares held
1,573,453
Last filed at
Oct 30, 2024
Confidence Score
49.9
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
842,162
Last filed at
Oct 2, 2025
Confidence Score
38.3
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
714,095
Last filed at
Aug 11, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
PASG - Passage BIO, Inc.
Role: 10% Owner
Shares held
708,352
Last filed at
Mar 3, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
Shares held
231,211
Last filed at
Jun 7, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
Shares held
198,485
Last filed at
Oct 20, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
LVTX - LAVA Therapeutics NV
Role: 10% Owner
Shares held
0
Last filed at
Sep 23, 2025
Confidence Score
40.6
2025Q4
Confidence Score History
2025Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 30, 2025 Oct 2, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 15.0 -224,974 -11.03% ✗ $10.4M
Sep 19, 2025 Sep 23, 2025 LAVA Therapeutics NV 10% Owner Sell 17.5 -2,903,403 -100.00% ✗ $4.1M
Sep 18, 2025 Sep 22, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 16.3 -135,304 -6.22% ✗ $5.7M
Sep 16, 2025 Sep 18, 2025 LAVA Therapeutics NV 10% Owner Sell 17.5 -1,684,434 -36.72% ✗ $2.5M
Aug 22, 2025 Aug 26, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 16.3 -188,094 -7.96% ✗ $7.4M
Aug 15, 2025 Aug 19, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 15.0 -260,713 -9.94% ✗ $10.3M
Jul 10, 2025 Jul 14, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 16.3 -191,376 -5.23% ✗ $6.5M
Jun 27, 2025 Jul 1, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 16.3 -200,000 -5.18% ✗ $6.1M
Jun 18, 2025 Jun 20, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 15.0 -334,801 -9.99% ✗ $10.1M
Jun 10, 2025 Jun 12, 2025 LENZ Therapeutics, Inc. 10% Owner Sell 15.0 -350,000 -9.46% ✗ $10.2M
Oct 28, 2024 Oct 30, 2024 Monte Rosa Therapeutics, Inc. 10% Owner Sell 17.5 -1,544,352 -12.37% ✗ $1.5M
Sep 20, 2024 Sep 24, 2024 Monte Rosa Therapeutics, Inc. 10% Owner Sell 16.3 -1,132,566 -13.60% ✗ $7.4M
Sep 11, 2024 Sep 13, 2024 Monte Rosa Therapeutics, Inc. 10% Owner Sell 17.5 -567,213 -6.38% ✗ $3.4M
Aug 28, 2024 Aug 30, 2024 Black Diamond Therapeutics, Inc. 10% Owner Sell 17.5 -221,600 -3.45% ✗ $1.4M
Aug 8, 2024 Aug 12, 2024 Tempest Therapeutics, Inc. 10% Owner Sell 20.0 -787,999 -18.35% ✗ $967K
Aug 9, 2022 Aug 11, 2022 Century Therapeutics, Inc. 10% Owner Sell 26.3 -914,800 -6.99% ✓ $7.2M
Jun 3, 2022 Jun 7, 2022 Repare Therapeutics Inc. 10% Owner Sell 16.3 -1,450,000 -22.51% ✗ $9.2M
Jun 29, 2021 Jul 1, 2021 LENZ Therapeutics, Inc. 10% Owner Buy 100.0 +180,000 11.78% ✗ $3.1M
Jun 28, 2021 Jun 30, 2021 Monte Rosa Therapeutics, Inc. 10% Owner Buy 95.0 +157,895 8.14% ✗ $3M
Jun 22, 2021 Jun 23, 2021 Century Therapeutics, Inc. 10% Owner Buy 100.0 +100,000 16.28% ✗ $2M
Nov 27, 2020 Dec 1, 2020 Black Diamond Therapeutics, Inc. 10% Owner Sell 30.0 -435,568 -6.23% ✓ $344.5K
Nov 19, 2020 Nov 23, 2020 Black Diamond Therapeutics, Inc. 10% Owner Sell 36.3 -130,017 -2.20% ✓ $4.3M
Nov 17, 2020 Nov 19, 2020 Black Diamond Therapeutics, Inc. 10% Owner Sell 51.3 -4,730 -0.08% ✓ $156.3K
Nov 13, 2020 Nov 17, 2020 Black Diamond Therapeutics, Inc. 10% Owner Sell 51.3 -4,700 -0.08% ✓ $158.6K
Nov 11, 2020 Nov 13, 2020 Black Diamond Therapeutics, Inc. 10% Owner Sell 26.3 -965,598 -8.98% ✓ $532.6K
Nov 10, 2020 Nov 12, 2020 Black Diamond Therapeutics, Inc. 10% Owner Sell 42.5 -39,583 -0.59% ✓ $1.4M
Nov 6, 2020 Nov 10, 2020 Black Diamond Therapeutics, Inc. 10% Owner Sell 47.5 -9,400 -0.14% ✓ $310.9K
Nov 4, 2020 Nov 6, 2020 Black Diamond Therapeutics, Inc. 10% Owner Sell 47.5 -11,348 -0.17% ✓ $376.1K
Oct 26, 2020 Oct 28, 2020 Black Diamond Therapeutics, Inc. 10% Owner Sell 47.5 -8,903 -0.13% ✓ $296.3K
Oct 15, 2020 Oct 20, 2020 Black Diamond Therapeutics, Inc. 10% Owner Sell 47.5 -15,746 -0.23% ✓ $526.5K
Oct 20, 2020 Oct 20, 2020 Aligos Therapeutics, Inc. 10% Owner Buy 100.0 +200,000 30.19% ✗ $3M
Oct 13, 2020 Oct 15, 2020 Black Diamond Therapeutics, Inc. 10% Owner Sell 46.3 -17,240 -0.26% ✓ $574K
Oct 8, 2020 Oct 13, 2020 Black Diamond Therapeutics, Inc. 10% Owner Sell 46.3 -22,625 -0.33% ✓ $757.9K
Oct 6, 2020 Oct 8, 2020 Black Diamond Therapeutics, Inc. 10% Owner Sell 36.3 -335,534 -2.97% ✓ $1.5M
Aug 10, 2020 Aug 12, 2020 Black Diamond Therapeutics, Inc. 10% Owner Sell 47.5 -13,792 -0.17% ✓ $456K
Jan 7, 2020 Jul 10, 2020 Akero Therapeutics, Inc. 10% Owner Sell 40.0 -53,057 -1.83% ✓ $1.1M
Jan 2, 2020 Jul 10, 2020 Akero Therapeutics, Inc. 10% Owner Sell 36.3 -756,587 -2.58% ✓ $1.4M
Jun 23, 2020 Jun 25, 2020 Repare Therapeutics Inc. 10% Owner Buy 96.3 +250,000 6.62% ✗ $5M
Mar 3, 2020 Mar 3, 2020 Passage BIO, Inc. 10% Owner Buy 100.0 +225,000 31.76% ✗ $4.1M
Feb 3, 2020 Feb 5, 2020 Black Diamond Therapeutics, Inc. 10% Owner Buy 97.5 +894,736 8.96% ✗ $17M
Jan 16, 2020 Jan 21, 2020 Akero Therapeutics, Inc. 10% Owner Sell 40.0 -59,532 -1.89% ✓ $1.2M
Jan 10, 2020 Jan 15, 2020 Akero Therapeutics, Inc. 10% Owner Sell 40.0 -50,837 -1.59% ✓ $1M
Jan 7, 2020 Jan 9, 2020 Akero Therapeutics, Inc. 10% Owner Sell 40.0 -53,057 -1.63% ✓ $1.1M
Jan 2, 2020 Jan 6, 2020 Akero Therapeutics, Inc. 10% Owner Sell 36.3 -756,587 -2.32% ✓ $1.4M
Dec 27, 2019 Dec 31, 2019 Akero Therapeutics, Inc. 10% Owner Sell 22.5 -389,382 -9.62% ✓ $9.4M
Dec 27, 2019 Dec 31, 2019 Akero Therapeutics, Inc. 10% Owner Sell 22.5 -389,382 -9.62% ✓ $9.4M
Dec 20, 2019 Dec 26, 2019 Akero Therapeutics, Inc. 10% Owner Sell 40.0 -49,220 -1.20% ✓ $1.1M
Dec 17, 2019 Dec 19, 2019 Akero Therapeutics, Inc. 10% Owner Sell 50.0 -9,671 -0.24% ✓ $189.2K
Jun 24, 2019 Jun 25, 2019 Akero Therapeutics, Inc. 10% Owner Buy 100.0 +400,000 10.80% ✗ $6.4M